Cargando…

Function, Adjustment, Quality of Life and Symptoms (FAQS) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Survivors: A Study Protocol

BACKGROUND: The population of survivors following allogeneic HSCT continues to increase, and yet their experiences of recovery and long-term survivorship have not been fully characterized. This paper presents a study protocol examining over time the functional status, psychosocial adjustment, health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bevans, Margaret F, Mitchell, Sandra A, Barrett, A John, Bishop, Michael, Childs, Richard, Fowler, Daniel, Krumlauf, Michael, Prince, Patricia, Shelburne, Nonniekaye, Wehrlen, Leslie
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101119/ https://www.ncbi.nlm.nih.gov/pubmed/21496339 http://dx.doi.org/10.1186/1477-7525-9-24

Ejemplares similares

Cardiometabolic risk factors and health behaviors in family caregivers
por: Ross, Alyson, et al.
Publicado: (2017)

Fellows FAQ
por: Thomas-Chevreux, Katharine
Publicado: (2014)

C++ FAQs
por: Cline, Marshall P, et al.
Publicado: (1999)

Personalized medicine: FAQs
por: Rajkumar, T.
Publicado: (2010)

FAQ-LHC The guide
por: Lopes, Ana, et al.
Publicado: (2022)

Tuberculosis: Just the FAQs
por: Guinn, Kristine M., et al.
Publicado: (2017)

FAQs für Allergiker
por: Pfützner, Wolfgang
Publicado: (2021)

Endocrine Sequelae in 157 Pediatric Survivors of Hematopoietic Stem Cell Transplantation (HSCT)
por: Güemes, María, et al.
Publicado: (2022)

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
por: Morris, Emma C., et al.
Publicado: (2019)

Photoshop Lightroom 4 FAQs
por: Sholik, Stan
Publicado: (2012)

START Learning by Sharing: FAQs
por: Rodvold, Keith A.
Publicado: (2009)

ISSN Roundtable: FAQs About the ISSN
por: Antonio, Jose, et al.
Publicado: (2005)

CERN Brochure - LHC Guide FAQ's
por: Press, Office
Publicado: (2010)

Official Eclipse 3.0 FAQs
por: Arthorne, John, et al.
Publicado: (2004)

Optimized Transformer Models for FAQ Answering
por: Damani, Sonam, et al.
Publicado: (2020)

FAQs about Submission to JACS Au
por: Jones, Christopher W.
Publicado: (2021)

Allergen-Immuntherapie: Facts und FAQs
por: Mortasawi, V., et al.
Publicado: (2021)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

926. Risk factors for post-letermovir cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell transplant (HSCT) recipients
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Take control of iTunes 12: the FAQ
por: McElhearn, Kirk
Publicado: (2017)

COVID19: Swiss and French cards FAQ
por: Cook, Anna
Publicado: (2020)

COVID-19 FAQs in Pediatric Cardiac Surgery
por: Levy, Emily, et al.
Publicado: (2020)

Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020)

COVID-19 and HSCT (Hematopoietic stem cell transplant)
por: Strasfeld, Lynne
Publicado: (2022)

Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
por: López-Sánchez, Cristina, et al.
Publicado: (2020)

Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers
por: Tsilifis, Christo, et al.
Publicado: (2023)

Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors
por: Jain, Natasha A., et al.
Publicado: (2020)

The SGML FAQ book: understanding the foundation of HTML and XML
por: De Rose, Steven J
Publicado: (1997)

Encephalitozoon intestinalis: A Rare Cause of Diarrhea in an Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipient Complicated by Albendazole-Related Hepatotoxicity
por: Şıvgın, Serdar, et al.
Publicado: (2013)

Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT)
por: Ramzi, Mani, et al.
Publicado: (2020)

PB2407: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) WITH CYCLOPHOSPHAMIDE IN PEDIATRIC HIGH-RISK ACUTE MYELOID LEUKEMIA (HR-AML)
por: Sun, Ming, et al.
Publicado: (2023)

PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
por: Ussmann, Jule, et al.
Publicado: (2023)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
por: Mohseni, Rashin, et al.
Publicado: (2023)

Multiple breath washout and oscillometry after allogenic HSCT: a scoping review
por: Sonneveld, Nicole, et al.
Publicado: (2023)

The Women's Health Questionnaire (WHQ): Frequently Asked Questions (FAQ)
por: Hunter, Myra S
Publicado: (2003)

Publication process at Lung India: Some FAQs and the editorial perspective
por: Singh, Virendra, et al.
Publicado: (2013)

COVID-19: FAQs in Pediatric Cardiac Surgery—A Sequel
por: Levy, Emily, et al.
Publicado: (2020)

Web-based chatbot for Frequently Asked Queries (FAQ) in Hospitals
por: Mittal, Mamta, et al.
Publicado: (2021)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sb4ais97qk7pth18jd9un2n548